D4.3a - Report on cost/benefit analysis (M24)

Taking into account the Western Medicine (WM) costs increased year by year, the Traditional Chinese Medicine (TCM) with more than two thousand years history is an economic and good therapy. A number of studies have shown that TCM in some treatments is better than WM: it can therefore be a good choice to introduce the TCM into the health care system in Europe.
Considering TCM as a kind of Complementary and Alternative Medicine in Europe, this report analyses the feasibility by cost-benefit analysis as a tool of Economic Evaluation. In this report, the cost involves the establishment of management system of TCM. And the benefit involves the saving by the use of TCM or integrative medicine of (TCM & WM) instead of WM in some treatments.